Podcast Episodes
Back to SearchMPN diagnosis & treatment: novel agents in PV, clinical guidance for the use of JAK inhibitors & the growing role of combination approaches
Episode 221
The treatment and management of myeloproliferative neoplasms (MPNs) including myelofibrosis (MF) and polycythemia vera (PV) has transformed in recent…
2 years, 10 months ago
iwNHL 2023 Session II: The evolving treatment landscape in mantle cell lymphoma
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as they discussed …
2 years, 11 months ago
iwNHL 2023 Session II: The evolving treatment landscape in mantle cell lymphoma
Episode 220
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as they discussed …
2 years, 11 months ago
iwNHL 2023 Session I: Updates on the biology and treatment of T-cell lymphoma
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as they discussed …
2 years, 11 months ago
iwNHL 2023 Session I: Updates on the biology and treatment of T-cell lymphoma
Episode 219
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as they discussed …
2 years, 11 months ago
iwAL 2023 Session IV: Transplantation and immunotherapies in AML: improving patient outcomes
The 5th International Workshop on Acute Leukemias (iwAL 2023) took place in San Diego, CA, and brought together leading experts in acute myeloid leuk…
2 years, 11 months ago
iwAL 2023 Session IV: transplantation and immunotherapies in AML: improving patient outcomes
Episode 218
The 5th International Workshop on Acute Leukemias (iwAL 2023) took place in San Diego, CA, and brought together leading experts in acute myeloid leuk…
2 years, 11 months ago
Classifying frailty and approaching elderly patients with lymphoma
While the treatment landscape of both Hodgkin and non-Hodgkin lymphoma (HL; NHL) has improved in recent years, there are several challenges associate…
2 years, 11 months ago
Classifying frailty and approaching elderly patients with lymphoma
Episode 217
While the treatment landscape of both Hodgkin and non-Hodgkin lymphoma (HL; NHL) has improved in recent years, there are several challenges associate…
2 years, 11 months ago
Updates on the diagnosis, risk stratification and treatment of lower-risk MDS
The treatment and management of lower-risk myelodysplastic syndromes (LR-MDS) has remained a challenge in the field, and several studies are being co…
3 years ago